These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11377492)

  • 1. Anti-CD4-induced long-term acceptance of rat liver allografts in a high-responder model is not based on pure immunosuppression.
    Kohlhaw K; Sack U; Lehmann I; Drews G; Schwarz R; Hartwig T; Tannapfel A; Berr F; Oertel M; Marx U; Lehmann M; Witterkind C; Hauss J; Emmrich F
    Transplant Proc; 2001 May; 33(3):2173-5. PubMed ID: 11377492
    [No Abstract]   [Full Text] [Related]  

  • 2. The monoclonal anti-CD4 antibody RIB5/2 induces donor-specific tolerance in the high-responder liver transplant model in the rat.
    Kohlhaw K; Sack U; Lehmann I; Drews G; Schwarz R; Hartwig T; Tannapfel A; Berr F; Oertel M; Marx U; Lehmann M; Wittekind C; Hauss J; Emmrich F
    Transplant Proc; 2001 May; 33(3):2371-3. PubMed ID: 11377563
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose dependent immunosuppressive effects of antibodies to ICAM-1 and LFA-1 on hepatic allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M
    Transplant Proc; 1996 Jun; 28(3):1794-5. PubMed ID: 8658886
    [No Abstract]   [Full Text] [Related]  

  • 4. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M
    Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698
    [No Abstract]   [Full Text] [Related]  

  • 5. Blocking of ICAM-1 and LFA-1 in rat liver transplantation.
    Degawa H; Watanabe K; Uchida H; Nagao T; Tomikawa S; Beck Y; Nomura Y; Ichikawa N; Ando Y; Kikuchi K; Ito S
    Transplant Proc; 1996 Jun; 28(3):1362-3. PubMed ID: 8658695
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1.
    Harihara Y; Sakamoto H; Sanjo K; Otsubo O; Watanabe G; Idezuki Y
    Transplant Proc; 1994 Aug; 26(4):2258. PubMed ID: 7915063
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abolition of anti-CD4-induced allotransplantation tolerance by exogenous IL-2.
    Lehmann M; Risch K; Nizze H; Brandenburg G; Ritter T; Brock J; Volk HD
    Transplant Proc; 1999; 31(1-2):1220-1. PubMed ID: 10083545
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
    Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
    Motoyama K; Lehmann M; Flye MW
    Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
    [No Abstract]   [Full Text] [Related]  

  • 12. Mice treated with anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase.
    Niimi M; Takashina M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Kameyama K; Matsumoto K; Hamano K; Esato K
    Transplant Proc; 2000 Nov; 32(7):2086. PubMed ID: 11120078
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive effects of monoclonal antibodies against adhesion molecules in rat pancreas allografts.
    Kawabe A; Suzuki H; Kimura T; Harada Y; Tamatani T; Miyasaka M
    Transplant Proc; 1994 Aug; 26(4):1937-8. PubMed ID: 7915055
    [No Abstract]   [Full Text] [Related]  

  • 15. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term graft acceptance after rat liver allograft transplantation induced by application of CTLA4-Ig and donor specific spleen cell administration.
    Neumann UP; Fischer U; Schmitz V; Lang M; Langrehr JM; Neuhaus P
    Transplant Proc; 2002 Aug; 34(5):1400-1. PubMed ID: 12176414
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy.
    Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG
    Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
    Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
    Transplant Proc; 2000 Nov; 32(7):2035. PubMed ID: 11120054
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.